Price$159.67-22.83 (-12.51%)
2026-03-042026-06-05
News · 26 weeks44-86%
2025-12-142026-06-07
Mix1090d
- SEC Filings4(40%)
- Other3(30%)
- Earnings2(20%)
- Insider1(10%)
Latest news
25 items- PRBalchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026MONTVALE, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the Wells Fargo Industrials Conference on June 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest qua
- SECSEC Form 10-Q filed by Balchem Corporation10-Q - BALCHEM CORP (0000009326) (Filer)
- SECBalchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BALCHEM CORP (0000009326) (Filer)
- PRBalchem Corporation Reports First Quarter 2026 Financial ResultsMONTVALE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2026 fiscal first quarter ended March 31, 2026. For the quarter, the Company reported net sales of $270.7 million, net earnings of $40.3 million, adjusted EBITDA(a) of $74.3 million, and free cash flow(a) of $33.8 million. Ted Harris, Chairman, President and CEO of Balchem said, "The first quarter was an excellent start to the year for Balchem, with sales and earnings growth in all three segments. We delivered record first quarter net sales, adjusted EBITDA, and net earnings, as well as strong cash flows." First Quarter 2026 Financial Highlights: Net sales were $
- SECSEC Form SCHEDULE 13G filed by Balchem CorporationSCHEDULE 13G - BALCHEM CORP (0000009326) (Subject)
- SECSEC Form DEF 14A filed by Balchem CorporationDEF 14A - BALCHEM CORP (0000009326) (Filer)
- SECSEC Form DEFA14A filed by Balchem CorporationDEFA14A - BALCHEM CORP (0000009326) (Filer)
- PRBalchem Corporation Releases 2025 Sustainability ReportMONTVALE, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today published its 2025 Sustainability Report. Our 2025 Sustainability Report centers on the areas where Balchem can create the most meaningful impact and offers a clear, actionable view of our ongoing sustainability journey. The priority topics addressed in the report were identified through continuous engagement with a broad range of internal and external stakeholders, enabling us to understand their sustainability interests and concerns. "I am pleased with the progress Balchem continues to make in advancing our broad-based sustainability efforts, as detailed in our 2025 Sustainability Report." said T
- PRBalchem Corporation Announces Quarterly Conference Call for First Quarter 2026 Financial Results on April 30, 2026MONTVALE, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) today announced that a conference call will be held on Thursday, April 30, 2026, at 11:00 AM Eastern Time (ET) to review first quarter results. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will host the call. First quarter results will be published prior to the market opening on Thursday, April 30, 2026. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call. Institutional investors, analysts and other members of the financial community are invited to join the live call by
- INSIDERSEC Form 3 filed by new insider Gilson Erin Leigh3 - BALCHEM CORP (0000009326) (Issuer)
- PRBalchem Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform to Deliver Research-Driven Nutrient Recommendations for Specialty CropsMONTVALE, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Balchem Plant Nutrition, a global leader in chelated mineral plant nutrition and the maker of Metalosate® micronutrients, today announced the launch of its Metalosate® T.E.A.M.™ plant tissue analysis digital platform. The platform helps advisors optimize nutrient balance to enhance yield potential and crop quality, while reducing unnecessary input cost in specialty crops. Built as a free service for pest control advisors and agronomists, T.E.A.M. translates plant tissue analysis results into targeted nutrition recommendations that growers can act on with confidence. T.E.A.M., which stands for Technical Evaluation of Albion Minerals, is a
- PRBalchem Corporation to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026MONTVALE, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the
- PRBalchem Corporation to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026MONTVALE, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference. About Balchem Corporation Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest
- SECSEC Form 10-K filed by Balchem Corporation10-K - BALCHEM CORP (0000009326) (Filer)
- SECBalchem Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - BALCHEM CORP (0000009326) (Filer)
- PRBalchem Corporation Reports Fourth Quarter and Full Year 2025 Financial ResultsMONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ:BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and free cash flow of $173.6 million. Ted Harris, Chairman, President, and CEO of Balchem said, "In the fourth quarter, Balchem's strong growth trajectory continued. We delivered record fo
- SECBalchem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - BALCHEM CORP (0000009326) (Filer)
- INSIDERSVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 1,775 shares and covered exercise/tax liability with 814 shares, increasing direct ownership by 10% to 10,149 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERSVP Chief Supply Chain Officer Reid Martin Luther was granted 3,299 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 30% to 9,073 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERChairman, President & CEO Harris Theodore L was granted 25,641 shares and covered exercise/tax liability with 10,202 shares, increasing direct ownership by 20% to 91,373 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERSVP and Chief R&D Officer Graham George was granted 700 shares, increasing direct ownership by 28% to 3,200 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERVP & Chief Accounting Officer Backus William A. was granted 2,154 shares and covered exercise/tax liability with 935 shares, increasing direct ownership by 22% to 6,736 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERSVP/GM, Human Nutri. & Health Boned Frederic was granted 5,117 shares and covered exercise/tax liability with 1,354 shares, increasing direct ownership by 72% to 8,978 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDERSVP & Chief HR Officer Tignor Michael Brent was granted 3,129 shares and covered exercise/tax liability with 1,156 shares, increasing direct ownership by 23% to 10,723 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
- INSIDEREVP, CLO, & Secretary Miyata Hatsuki was granted 3,957 shares and covered exercise/tax liability with 1,058 shares, increasing direct ownership by 50% to 8,745 units (SEC Form 4)4 - BALCHEM CORP (0000009326) (Issuer)
BCPC FAQ
6 questionsWhat does Balchem Corporation do?
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid...Where does BCPC stock trade?
Balchem Corporation (BCPC) is listed on NASDAQ.What sector and industry is BCPC in?
Balchem Corporation operates in the Industrials sector, Major Chemicals industry.What are analysts saying about BCPC?
Balchem Corporation has had 7 recent analyst actions on file. The most recent action was from Rothschild & Co Redburn: Neutral on 2025-12-05.What companies are similar to BCPC?
Notable peers in the same industry include LIN (Linde plc), APD (Air Products and Chemicals Inc.), DOW (Dow Inc.), LYB (LyondellBasell Industries NV), DD (DuPont de Nemours Inc.). Compare BCPC side-by-side with any of them on Quantisnow.How can I track BCPC on Quantisnow?
Quantisnow aggregates Balchem Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BCPC to receive live email and push alerts on every new disclosure.